1CE1
 
 | | 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN | | Descriptor: | PROTEIN (CAMPATH-1H:HEAVY CHAIN), PROTEIN (CAMPATH-1H:LIGHT CHAIN), PROTEIN (PEPTIDE ANTIGEN) | | Authors: | James, L.C, Hale, G, Waldmann, H, Bloomer, A.C. | | Deposit date: | 1999-03-12 | | Release date: | 1999-06-25 | | Last modified: | 2023-12-27 | | Method: | X-RAY DIFFRACTION (1.9 Å) | | Cite: | 1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen.
J.Mol.Biol., 289, 1999
|
|
6R8C
 | | HIV capsid hexamer with IP5 ligand | | Descriptor: | Gag polyprotein, MYO-INOSITOL-(1,3,4,5,6)-PENTAKISPHOSPHATE | | Authors: | James, L.C. | | Deposit date: | 2019-04-01 | | Release date: | 2020-05-06 | | Last modified: | 2024-01-24 | | Method: | X-RAY DIFFRACTION (1.92 Å) | | Cite: | HIV hexamer
to be published
|
|
6R6Q
 | |
6ERM
 | | HIV Hexamer with ligand | | Descriptor: | 3'-AZIDO-3'-DEOXYTHYMIDINE-5'-TRIPHOSPHATE, Gag polyprotein | | Authors: | James, L.C. | | Deposit date: | 2017-10-18 | | Release date: | 2018-11-07 | | Last modified: | 2024-01-17 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | HIV hexamer
To Be Published
|
|
6ERN
 | | HIV Hexamer with ligand | | Descriptor: | ADENOSINE-5'-TRIPHOSPHATE, Gag polyprotein | | Authors: | James, L.C. | | Deposit date: | 2017-10-18 | | Release date: | 2018-11-07 | | Last modified: | 2020-04-01 | | Method: | X-RAY DIFFRACTION (2.36 Å) | | Cite: | HIV hexamer
To Be Published
|
|
7OVX
 | | E3 RING ligase binding domain | | Descriptor: | E3 ubiquitin-protein ligase TRIM7, Peptide G | | Authors: | James, L.C. | | Deposit date: | 2021-06-15 | | Release date: | 2022-06-22 | | Last modified: | 2024-01-31 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | E3 ligase targeting domain
To Be Published
|
|
7OW2
 | | E3 RING ligase binding domain with peptide | | Descriptor: | CHLORIDE ION, E3 ubiquitin-protein ligase RNF187 peptide, E3 ubiquitin-protein ligase TRIM7, ... | | Authors: | James, L.C. | | Deposit date: | 2021-06-16 | | Release date: | 2022-07-13 | | Last modified: | 2024-01-31 | | Method: | X-RAY DIFFRACTION (2.17 Å) | | Cite: | E3 ligase targeting domain
To Be Published
|
|
2BJM
 | | SPE7:Anthrone Complex | | Descriptor: | ANTHRONE, IGE SPE7 HEAVY CHAIN, IGE SPE7 LIGHT CHAIN | | Authors: | James, L.C, Tawfik, D.S. | | Deposit date: | 2005-02-04 | | Release date: | 2005-08-18 | | Last modified: | 2013-10-30 | | Method: | X-RAY DIFFRACTION (2.15 Å) | | Cite: | Structure and Kinetics of a Transient Antibody Binding Intermediate Reveal a Kinetic Discrimination Mechanism in Antigen Recognition
Proc.Natl.Acad.Sci.USA, 102, 2005
|
|
2BX5
 | | Is FR1 the antibody's Achillies heel | | Descriptor: | VD9 VKI LIGHT-CHAIN | | Authors: | James, L.C. | | Deposit date: | 2005-07-22 | | Release date: | 2006-11-15 | | Last modified: | 2023-12-13 | | Method: | X-RAY DIFFRACTION (2.7 Å) | | Cite: | Beta-Edge Interactions in a Pentadecameric Human Antibody Vkappa Domain.
J.Mol.Biol., 367, 2007
|
|
1OAX
 | |
1OAZ
 | |
1OAR
 | | Fv IgE SPE-7 in complex with Alizarin Red | | Descriptor: | 1,2-ETHANEDIOL, ALIZARIN RED, CACODYLATE ION, ... | | Authors: | James, L.C, Roversi, P, Tawfik, D. | | Deposit date: | 2003-01-21 | | Release date: | 2004-01-15 | | Last modified: | 2013-10-30 | | Method: | X-RAY DIFFRACTION (2.23 Å) | | Cite: | Antibody Multispecificity Mediated by Conformational Diversity
Science, 299, 2003
|
|
1OAU
 | | Fv Structure of the IgE SPE-7 in complex with DNP-Ser (immunising hapten) | | Descriptor: | 2,4-DINITROPHENOL, IMIDAZOLE, IMMUNOGLOBULIN E, ... | | Authors: | James, L.C, Roversi, P, Tawfik, D. | | Deposit date: | 2003-01-21 | | Release date: | 2004-01-15 | | Last modified: | 2013-10-30 | | Method: | X-RAY DIFFRACTION (1.8 Å) | | Cite: | Antibody Multispecificity Mediated by Conformational Diversity
Science, 299, 2003
|
|
1OAY
 | |
1OAQ
 | |
1OCW
 | |
2IWG
 | | COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC | | Descriptor: | 52 KDA RO PROTEIN, IG GAMMA-1 CHAIN C, alpha-L-fucopyranose, ... | | Authors: | James, L.C, Keeble, A.H, Rhodes, D.A, Trowsdale, J. | | Deposit date: | 2006-06-30 | | Release date: | 2007-03-27 | | Last modified: | 2020-07-29 | | Method: | X-RAY DIFFRACTION (2.35 Å) | | Cite: | Structural Basis for Pryspry-Mediated Tripartite Motif (Trim) Protein Function.
Proc.Natl.Acad.Sci.USA, 104, 2007
|
|
4V1P
 | | BTN3 Structure | | Descriptor: | BUTYROPHILIN SUBFAMILY 3 MEMBER A1 | | Authors: | James, L.C. | | Deposit date: | 2014-09-30 | | Release date: | 2015-07-22 | | Method: | X-RAY DIFFRACTION (2.04 Å) | | Cite: | Activation of Human Gammadelta T Cells by Cytosolic Interactions of Btn3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin.
J.Immunol., 194, 2015
|
|
8A58
 | |
6ES8
 | | HIV capsid hexamer with IP6 ligand | | Descriptor: | Gag protein, INOSITOL HEXAKISPHOSPHATE | | Authors: | James, L.C. | | Deposit date: | 2017-10-19 | | Release date: | 2018-08-15 | | Last modified: | 2024-01-17 | | Method: | X-RAY DIFFRACTION (1.9 Å) | | Cite: | IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis.
Elife, 7, 2018
|
|
6H09
 | | HIV capsid hexamer with IP6 ligand | | Descriptor: | Gag polyprotein, INOSITOL HEXAKISPHOSPHATE | | Authors: | James, L.C. | | Deposit date: | 2018-07-06 | | Release date: | 2018-08-15 | | Last modified: | 2020-10-07 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis.
Elife, 7, 2018
|
|
3ZO0
 | | Mouse IgG2a in complex with mouse TRIM21 PRYSPRY | | Descriptor: | E3 UBIQUITIN-PROTEIN LIGASE TRIM21, IG GAMMA-2A CHAIN C REGION, A ALLELE, ... | | Authors: | James, L.C. | | Deposit date: | 2013-02-19 | | Release date: | 2013-05-22 | | Last modified: | 2020-07-29 | | Method: | X-RAY DIFFRACTION (1.99 Å) | | Cite: | Trim21 is an Igg Receptor that is Structurally, Thermodynamically, and Kinetically Conserved.
Proc.Natl.Acad.Sci.USA, 105, 2008
|
|
5OLM
 | | TRIM21 | | Descriptor: | E3 ubiquitin-protein ligase TRIM21, ZINC ION | | Authors: | James, L.C. | | Deposit date: | 2017-07-28 | | Release date: | 2018-04-25 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21.
Elife, 7, 2018
|
|
7BBD
 | | Crystal structure of monoubiquitinated TRIM21 RING (Ub-RING) In complex with ubiquitin charged Ube2N (Ube2N~Ub) and Ube2V2 | | Descriptor: | Polyubiquitin-B,E3 ubiquitin-protein ligase TRIM21, Polyubiquitin-C, Ubiquitin-conjugating enzyme E2 N, ... | | Authors: | Kiss, L, Neuhaus, D, James, L.C. | | Deposit date: | 2020-12-17 | | Release date: | 2021-01-27 | | Last modified: | 2024-01-31 | | Method: | X-RAY DIFFRACTION (2.2 Å) | | Cite: | RING domains act as both substrate and enzyme in a catalytic arrangement to drive self-anchored ubiquitination.
Nat Commun, 12, 2021
|
|
7BBF
 | |
